BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24182354)

  • 1. The association of TP53 mutations with the resistance of colorectal carcinoma to the insulin-like growth factor-1 receptor inhibitor picropodophyllin.
    Wang Q; Wei F; Lv G; Li C; Liu T; Hadjipanayis CG; Zhang G; Hao C; Bellail AC
    BMC Cancer; 2013 Nov; 13():521. PubMed ID: 24182354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Picropodophyllin inhibits tumor growth of human nasopharyngeal carcinoma in a mouse model.
    Yin SC; Guo W; Tao ZZ
    Biochem Biophys Res Commun; 2013 Sep; 439(1):1-5. PubMed ID: 23973483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells.
    Strömberg T; Feng X; Delforoush M; Berglund M; Lin Y; Axelson M; Larsson O; Georgii-Hemming P; Lennartsson J; Enblad G
    Med Oncol; 2015 Jul; 32(7):188. PubMed ID: 26021470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin.
    Vasilcanu R; Vasilcanu D; Sehat B; Yin S; Girnita A; Axelson M; Girnita L
    Mol Pharmacol; 2008 Mar; 73(3):930-9. PubMed ID: 18070930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling.
    Razuvaev A; Henderson B; Girnita L; Larsson O; Axelson M; Hedin U; Roy J
    J Vasc Surg; 2007 Jul; 46(1):108-15. PubMed ID: 17606126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The insulin-like growth factor-I receptor inhibitor picropodophyllin-induced selective apoptosis of hepatocellular carcinoma cell through a caspase-dependent mitochondrial pathway.
    E C; Li J; Shao D; Zhang D; Pan Y; Chen L; Zhang X
    Oncol Res; 2013; 21(2):103-10. PubMed ID: 24406046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway.
    Vasilcanu D; Girnita A; Girnita L; Vasilcanu R; Axelson M; Larsson O
    Oncogene; 2004 Oct; 23(47):7854-62. PubMed ID: 15334055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells.
    Strömberg T; Ekman S; Girnita L; Dimberg LY; Larsson O; Axelson M; Lennartsson J; Hellman U; Carlson K; Osterborg A; Vanderkerken K; Nilsson K; Jernberg-Wiklund H
    Blood; 2006 Jan; 107(2):669-78. PubMed ID: 16166596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of forced expression of mutated K-RAS gene on gastrointestinal cancer cell lines and the IGF-1R targeting therapy.
    Matsunaga Y; Adachi Y; Sasaki Y; Koide H; Motoya M; Nosho K; Takagi H; Yamamoto H; Sasaki S; Arimura Y; Tokino T; Carbone DP; Imai K; Shinomura Y
    Mol Carcinog; 2017 Feb; 56(2):515-526. PubMed ID: 27312358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The insulin-like growth factor-1 receptor inhibitor PPP produces only very limited resistance in tumor cells exposed to long-term selection.
    Vasilcanu D; Weng WH; Girnita A; Lui WO; Vasilcanu R; Axelson M; Larsson O; Larsson C; Girnita L
    Oncogene; 2006 May; 25(22):3186-95. PubMed ID: 16407828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines.
    Duan Z; Choy E; Harmon D; Yang C; Ryu K; Schwab J; Mankin H; Hornicek FJ
    Mol Cancer Ther; 2009 Aug; 8(8):2122-30. PubMed ID: 19638450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the insulin-like growth factor-1 receptor by picropodophyllin for lung cancer chemoprevention.
    Zhang Q; Pan J; Lubet RA; Wang Y; You M
    Mol Carcinog; 2015 Jun; 54 Suppl 1():E129-37. PubMed ID: 25163779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Picropodophyllin inhibits type I endometrial cancer cell proliferation via disruption of the PI3K/Akt pathway.
    Dong L; Du M; Lv Q
    Acta Biochim Biophys Sin (Shanghai); 2019 Jul; 51(7):753-760. PubMed ID: 31168597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple antitumor effects of picropodophyllin in colon carcinoma cell lines: clinical implications.
    Feng X; Aleem E; Lin Y; Axelson M; Larsson O; Strömberg T
    Int J Oncol; 2012 Apr; 40(4):1251-8. PubMed ID: 22159423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma.
    Yin S; Girnita A; Strömberg T; Khan Z; Andersson S; Zheng H; Ericsson C; Axelson M; Nistér M; Larsson O; Ekström TJ; Girnita L
    Neuro Oncol; 2010 Jan; 12(1):19-27. PubMed ID: 20150364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model.
    Menu E; Jernberg-Wiklund H; Stromberg T; De Raeve H; Girnita L; Larsson O; Axelson M; Asosingh K; Nilsson K; Van Camp B; Vanderkerken K
    Blood; 2006 Jan; 107(2):655-60. PubMed ID: 16046527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of IGF-1R signaling increases TRAIL-induced apoptosis: a new potential therapy for the treatment of melanoma.
    Karasic TB; Hei TK; Ivanov VN
    Exp Cell Res; 2010 Jul; 316(12):1994-2007. PubMed ID: 20417200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin Growth Factor 1 Protects Neural Stem Cells Against Apoptosis Induced by Hypoxia Through Akt/Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase (Akt/MAPK/ERK) Pathway in Hypoxia-Ishchemic Encephalopathy.
    Zhao B; Zheng Z
    Med Sci Monit; 2017 Apr; 23():1872-1879. PubMed ID: 28420864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
    Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2620-6. PubMed ID: 18515591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and beta-arrestin1.
    Vasilcanu R; Vasilcanu D; Rosengren L; Natalishvili N; Sehat B; Yin S; Girnita A; Axelson M; Girnita L; Larsson O
    Oncogene; 2008 Mar; 27(11):1629-38. PubMed ID: 17828296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.